Noro R, Igawa S, Bessho A, Hirose T, et al. A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632. Lung Cancer 2021;161:49-54.
PMID: 34536731